Status:
UNKNOWN
Radiofrequency Ablation Versus Balloon Cryoablation in Elderly Patients With Atrial Fibrillation
Lead Sponsor:
Vivantes Netzwerk für Gesundheit GmbH
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
75+ years
Phase:
NA
Brief Summary
This study compares the procedural characteristics and effectivity of radiofrequency ablation and cryoablation in patients with atrial fibrillation that are 75 years or older.
Detailed Description
Radiofrequency and cryoballon ablation have been shown to be comparable to each other in terms of safety and effectivity in patients with atrial fibrillation. However, elderly patients have been under...
Eligibility Criteria
Inclusion
- Patients with recurrent symptomatic paroxysmal or persistent atrial fibrillation
- At the day of their inclusion in the study the patients have to have completed the 75th year of life
Exclusion
- Dementia
- Presence of left atrial thrombus
- Left atrial volume\> 50 ml/m²
- Renal failure (GFR≤ 30 ml/min)
- Comorbidity with an expected survival of 12 months or less.
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04337567
Start Date
March 1 2020
End Date
January 31 2024
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vivantes Klinikum Neukölln
Berlin, Germany